Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
UnitedHealthcare and Optum Take Action to Support People Affected by Winter Storm in North CarolinaBusiness Wire
Ellington Financial LLC Reports Estimated Book Value Per Share as of November 30, 2018Business Wire
Astrotech Announces Results from Fiscal Year 2018 Annual Meeting of ShareholdersBusiness Wire
Publicis Groupe: Press ReleaseBusiness Wire
Xylem Named to The JUST 100 America’s Best Corporate Citizens ListBusiness Wire
Energy Transfer LP Launches New Cash Distribution Reinvestment PlanBusiness Wire
CORRECTING and REPLACING Trovata Launches New Cash Automation PlatformBusiness Wire
Red Hat Sets Jan. 16, 2019, Special Meeting for Vote on Merger Agreement with IBMBusiness Wire
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Loma Negra Compania Industrial Argentina Sociedad AnonimaBusiness Wire
Lubrizol
Lubrizol Announces Strategic Alliance with Vidalia Denim for Sustainably-Produced Denim Featuring X4zol(TM)-J Stretch Fibers: OMX
Triton International Board Appoints Karen Austin to Board of DirectorsBusiness Wire
CereSpir Inc.
CERESPIR INCORPORATED und das NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE geben positive Daten bekannt, die eine vorteilhafte Wirkung des in der klinischen Erprobung befindlichen Wirkstoffs Itanapraced von CERESPIR in einem LRRK2-Modell der Parkinson-Krankheit zeigenOMX
CereSpir Inc.
CERESPIR有限公司和新加坡国立神经科学研究院宣布阳性数据显示,CERESPIR公司临床阶段化合物Itanapraced对帕金森病LRRK2模型具有益效果OMX
CereSpir Inc.
CERESPIR INCORPORATED et le NATIONAL NEUROSCIENCE INSTITUTE – SINGAPOUR annoncent des données positives montrant les effets bénéfiques du composé Itanapraced de CERESPIR au stade clinique dans un modèle LRRK2 de la maladie de ParkinsonOMX
CereSpir Inc.
CERESPIR有限公司及新加坡國立神經科學研究院宣佈正面數據顯示,CERESPIR公司臨床階段化合物Itanapraced對帕金森病LRRK2模型帶來有益效果OMX
CereSpir Inc.
CERESPIR INCORPORATED dan INSTITUT NEUROSAINS KEBANGSAAN SINGAPURA Mengumumkan Data Positif yang Menunjukkan Kesan Bermanfaat Sebatian Peringkat Klinikal Itanapraced CERESPIR dalam Model LRRK2 Penyakit ParkinsonOMX
CereSpir Inc.
セレスピールとシンガポール国立神経科学研究所が、パーキンソン病のLRRK2モデルにおけるセレスピールの臨床適用候補化合物イタナプラセド (Itanapraced) の有益効果を示す肯定的データを発表OMX
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Markel Corporation Investors (MKL)Business Wire
BlackRock Multi-Sector Opportunities Trust Announces DistributionBusiness Wire
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Arlo Technologies, Inc. InvestorsBusiness Wire
RNS announcements are delayed by up to an hour.
...